Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
259.06
-5.99 (-2.26%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Tenet Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21,812 | 21,310 | 20,675 | 20,564 | 19,174 | 19,485 | |
Revenue Growth | 5.41% | 3.07% | 0.54% | 7.25% | -1.60% | 10.46% |
Cost of Revenue | 12,725 | 12,493 | 12,456 | 12,743 | 12,126 | 12,217 |
Gross Profit | 9,087 | 8,817 | 8,219 | 7,821 | 7,048 | 7,268 |
Selling, General & Admin | 410 | 410 | 417 | 418 | 412 | 412 |
Other Operating Expenses | 3,833 | 3,772 | 3,766 | 3,728 | 3,310 | 3,439 |
Operating Expenses | 5,136 | 5,045 | 5,001 | 5,016 | 4,563 | 4,706 |
Operating Income | 3,951 | 3,772 | 3,218 | 2,805 | 2,485 | 2,562 |
Interest Expense | -820 | -821 | -826 | -901 | -890 | -923 |
Earnings From Equity Investments | 263 | 264 | 260 | 228 | 216 | 218 |
Other Non Operating Income (Expenses) | 158 | 125 | 134 | 26 | 20 | 25 |
EBT Excluding Unusual Items | 3,552 | 3,340 | 2,786 | 2,158 | 1,831 | 1,882 |
Merger & Restructuring Charges | -67 | -69 | -95 | -94 | -132 | -77 |
Gain (Loss) on Sale of Assets | 49 | -1 | 2,916 | 23 | 1 | 445 |
Asset Writedown | -75 | -61 | -7 | -43 | -94 | -8 |
Legal Settlements | -49 | -64 | -35 | -47 | -70 | -116 |
Other Unusual Items | 455 | -345 | -317 | -380 | -191 | -238 |
Pretax Income | 3,865 | 2,800 | 5,248 | 1,617 | 1,345 | 1,888 |
Income Tax Expense | 691 | 433 | 1,184 | 306 | 344 | 411 |
Earnings From Continuing Operations | 3,174 | 2,367 | 4,064 | 1,311 | 1,001 | 1,477 |
Earnings From Discontinued Operations | - | - | - | - | - | -1 |
Net Income to Company | 3,174 | 2,367 | 4,064 | 1,311 | 1,001 | 1,476 |
Minority Interest in Earnings | -933 | -960 | -864 | -700 | -590 | -562 |
Net Income | 2,241 | 1,407 | 3,200 | 611 | 411 | 914 |
Net Income to Common | 2,241 | 1,407 | 3,200 | 611 | 411 | 914 |
Net Income Growth | 51.01% | -56.03% | 423.73% | 48.66% | -55.03% | 129.07% |
Shares Outstanding (Basic) | 86 | 90 | 97 | 102 | 107 | 107 |
Shares Outstanding (Diluted) | 87 | 91 | 98 | 105 | 111 | 109 |
Shares Change | -8.21% | -7.20% | -6.60% | -5.17% | 1.79% | 2.17% |
EPS (Basic) | 25.94 | 15.61 | 33.02 | 6.01 | 3.84 | 8.56 |
EPS (Diluted) | 25.75 | 15.49 | 32.70 | 5.71 | 3.78 | 8.42 |
EPS Growth | 64.50% | -52.63% | 473.12% | 50.87% | -55.07% | 124.49% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3,023 | 2,530 | 1,116 | 1,623 | 321 | 910 |
Free Cash Flow Per Share | 34.74 | 27.85 | 11.40 | 15.49 | 2.90 | 8.38 |
Gross Margin | 41.66% | 41.38% | 39.75% | 38.03% | 36.76% | 37.30% |
Operating Margin | 18.11% | 17.70% | 15.57% | 13.64% | 12.96% | 13.15% |
Profit Margin | 10.27% | 6.60% | 15.48% | 2.97% | 2.14% | 4.69% |
Free Cash Flow Margin | 13.86% | 11.87% | 5.40% | 7.89% | 1.67% | 4.67% |
EBITDA | 4,844 | 4,635 | 4,036 | 3,675 | 3,326 | 3,417 |
EBITDA Margin | 22.21% | 21.75% | 19.52% | 17.87% | 17.35% | 17.54% |
D&A For EBITDA | 893 | 863 | 818 | 870 | 841 | 855 |
EBIT | 3,951 | 3,772 | 3,218 | 2,805 | 2,485 | 2,562 |
EBIT Margin | 18.11% | 17.70% | 15.57% | 13.64% | 12.96% | 13.15% |
Effective Tax Rate | 17.88% | 15.46% | 22.56% | 18.92% | 25.58% | 21.77% |